What was Mankind Pharma's net profit in the third quarter?

Mankind Pharma's net profit in the third quarter rose by 7.5% year-on-year to ₹408.7 crore.

How did Mankind Pharma's revenue perform in the third quarter?

The company's revenue increased by 11.5% year-on-year, reaching ₹3,567 crore in the third quarter.

What factors impacted Mankind Pharma's performance in the second quarter?

In the second quarter, Mankind Pharma faced profitability pressures due to GST transition disruptions and adverse monsoon conditions affecting businesses.

Home / Business and Economy / Mankind Pharma Profit Soars 7.5% in Q3

Mankind Pharma Profit Soars 7.5% in Q3

3 Feb

•

Summary

Net profit rose 7.5% to ₹408.7 crore in Q3, a strong recovery.
Revenue increased 11.5% to ₹3,567 crore, driven by steady expansion.
Performance shows rebound after Q2 challenges like GST and monsoon.

Mankind Pharma has reported a substantial 7.5% year-on-year rise in net profit for the third quarter, reaching ₹408.7 crore. This financial upswing signifies a strong recovery from earlier setbacks in the fiscal year.

The company's revenue for the quarter experienced an 11.5% increase, totaling ₹3,567 crore. This growth was underpinned by consistent sales expansion and a slight improvement in operating margins, which moved to 25.8%.

This positive outcome contrasts with the second quarter, which saw profitability pressures despite revenue growth. Factors like GST disruptions and monsoon-related issues had impacted sales and consumer healthcare demand.

Mankind Pharma's stock closed on the NSE with a notable gain of 4.78%, indicating investor confidence following the improved quarterly results.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.